Actively Recruiting
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
Led by Hywel Dda Health Board · Updated on 2025-04-10
120
Participants Needed
1
Research Sites
248 weeks
Total Duration
On this page
Sponsors
H
Hywel Dda Health Board
Lead Sponsor
U
University of Aberdeen
Collaborating Sponsor
AI-Summary
What this Trial Is About
Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye that processes light into a nerve impulse. This leads to damage and blindness via various different mechanisms that are not fully understood. In this study the objective is to recruit people with diabetes and various stages of diabetic eye disease and measure a large number of different chemicals within the blood that might be associated with damage and dysfunction within the retina. Additionally, it will examine the different bacteria within the gut that might affect disease in the eye via chemicals circulating in the blood. This will require participants to have blood samples taken and to provide urine samples. The blood will be analysed with specialised instruments to identify specific molecules circulating within the blood. Participants will also need to allow researchers to look at their medical records, previous photographs and specialist scans of the back of the eye to grade their diabetic retinopathy. This will allow us to identify potential ways in which these could be targeted for future benefit for people with diabetes to hopefully prevent deterioration of their vision.
CONDITIONS
Official Title
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of type 2 diabetes mellitus
- Male or female aged 18 to 80 years inclusive
You will not qualify if you...
- Unable or unwilling to give consent for the study
- Prior treatment with intravitreal therapies for diabetic macular edema
- Known infectious diseases that may risk the study team (e.g., tuberculosis, HIV, hepatitis)
- Age 17 years or younger, or 81 years or older
- Known genetic conditions affecting lipid metabolism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince Philip Hospital
Llanelli, Wales, United Kingdom, SA14 8QF
Actively Recruiting
Research Team
F
Francis WB Sanders, MB BChir PhD FRCOphth
CONTACT
E
Eirini Skiadaresi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here